Search

everythinglearnresearchcommunity

for

Search:↓

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Disease-specific tools better assess alopecia areata's impact on quality of life.

A rare scalp infection in a 66-year-old woman was successfully treated, leading to full hair regrowth.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

New guidelines and referral pathways for skin conditions aim to improve care and referrals in Pakistan.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Oral minoxidil is an effective alternative for hair loss but may cause more unwanted hair growth.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

People in palliative care often have skin problems due to their main illness or other health issues, and treatments focus on comfort and quality of life.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

Tretinoin alone is more effective than combined with microdermabrasion for long-term alopecia areata treatment.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

Many COVID-19 patients, especially women, experienced hair loss, often linked to diabetes and lack of dietary supplements.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

Professor Danilo V. Stevanovic emphasized the importance of traditional dermatology practices and human connection.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Early-onset alopecia, especially with a family history, leads to worse outcomes and more related health issues.

Children with darker skin tones can have specific skin conditions that need tailored treatments.